NTLA – intellia therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

NTLA

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

1/28

07:19 am

ntla

Intellia Therapeutics (NASDAQ:NTLA) had its "buy" rating reaffirmed by analysts at HC Wainwright.

Medium Report

Intellia Therapeutics (NASDAQ:NTLA) had its "buy" rating reaffirmed by analysts at HC Wainwright.

Report

11/12

08:07 am

ntla

Intellia Therapeutics (NASDAQ:NTLA) had its "peer perform" rating reaffirmed by analysts at Wolfe Research.

Medium Report

Intellia Therapeutics (NASDAQ:NTLA) had its "peer perform" rating reaffirmed by analysts at Wolfe Research.

Report

11/12

08:07 am

ntla

Intellia Therapeutics (NASDAQ:NTLA) had its "peer perform" rating reaffirmed by analysts at Wolfe Research.

Medium Report

Intellia Therapeutics (NASDAQ:NTLA) had its "peer perform" rating reaffirmed by analysts at Wolfe Research.

Report

11/12

06:59 am

ntla

Rating for NTLA

Medium Report

Rating for NTLA

Report

11/12

06:59 am

ntla

Rating for NTLA

Medium Report

Rating for NTLA

Report

11/12

06:43 am

ntla

Intellia Therapeutics (NASDAQ:NTLA) was upgraded by analysts at Evercore ISI to a "hold" rating.

Medium Report

Intellia Therapeutics (NASDAQ:NTLA) was upgraded by analysts at Evercore ISI to a "hold" rating.

Report

11/12

06:43 am

ntla

Intellia Therapeutics (NASDAQ:NTLA) was upgraded by analysts at Evercore ISI to a "hold" rating.

Medium Report

Intellia Therapeutics (NASDAQ:NTLA) was upgraded by analysts at Evercore ISI to a "hold" rating.

Report

11/11

05:32 pm

ntla

Intellia Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research

Medium Report

Intellia Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research

Report

11/11

05:32 pm

ntla

Intellia Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research

Medium Report

Intellia Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research

Report

11/11

05:12 am

ntla

Rating for NTLA

Medium Report

Rating for NTLA

Report

11/11

04:50 am

ntla

Intellia Therapeutics downgraded to In Line from Outperform at Evercore ISI

Medium Report

Intellia Therapeutics downgraded to In Line from Outperform at Evercore ISI

Report

11/11

04:50 am

ntla

Intellia Therapeutics downgraded to In Line from Outperform at Evercore ISI

Medium Report

Intellia Therapeutics downgraded to In Line from Outperform at Evercore ISI

Report

11/7

06:09 pm

ntla

Rating for NTLA

Low Report

Rating for NTLA

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.